ANNUAL RESULTS
Venus Remedies Ltd.
BSE
Jun 13
457.75
+14.25 (+ 3.21%)
Volume
5204
Prev. Close
443.50
Open Price
448.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 13
457.30
+11.60 (+ 2.60%)
Volume
50234
Prev. Close
445.70
Open Price
437.90
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE411B01019
|
Market Cap. ( ₹ in Cr. )
|
611.27
|
P/BV
|
1.24
|
Book Value ( ₹ )
|
369.73
|
|
BSE Code
|
526953
|
52 Week High/Low ( ₹ )
|
477/270
|
FV/ML
|
10/1
|
P/E(X)
|
13.49
|
|
NSE Code
|
VENUSREMBE
|
Book Closure
|
23/09/2024
|
EPS ( ₹ )
|
33.90
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Net Sales/Income from operations | 639.46 | 575.21 | 537.66 | 575.18 | 514.62 |
| Total Income From Operations | 639.46 | 575.21 | 537.66 | 575.18 | 514.62 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 348.82 | 344.15 | 317.28 | 372.78 | 344.04 |
| Purchase of Traded Goods | 25.04 | 13.07 | 5.16 | 0.00 | 0.00 |
| Increase/Decrease in Stocks | 0.93 | -5.00 | 14.26 | 3.19 | -7.36 |
| Employees Cost | 72.24 | 62.13 | 51.95 | 43.75 | 35.89 |
| Depreciation | 21.62 | 25.55 | 31.37 | 32.58 | 34.28 |
| Admin. And Selling Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 79.32 |
| ResearchAndDevlopmentExpenses | 0.00 | 0.00 | 0.00 | 0.00 | 15.87 |
| Other Expenses | 122.44 | 99.98 | 87.48 | 86.65 | 0.00 |
| Total Expenses | 591.09 | 539.88 | 507.50 | 538.94 | 502.04 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 48.37 | 35.33 | 30.16 | 36.24 | 12.58 |
| Other Income | 20.78 | 11.32 | 10.17 | 8.43 | 17.76 |
| P/L Before Interest, Excpt. Items & Tax | 69.15 | 46.65 | 40.33 | 44.67 | 30.35 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 12.73 |
| P/L Before Exceptional Items & Tax | 69.15 | 46.65 | 40.33 | 44.67 | 17.62 |
| Exceptional Items | 9.91 | 0.00 | 0.00 | 0.00 | 23.44 |
| P/L Before Tax | 79.06 | 46.65 | 40.33 | 44.67 | 41.06 |
| Tax | 26.51 | 16.15 | 11.37 | -4.32 | -13.21 |
| P/L After Tax from Ordinary Activities | 52.55 | 30.50 | 28.96 | 48.99 | 54.27 |
| Net Profit/Loss For the Period | 52.55 | 30.50 | 28.96 | 48.99 | 54.27 |
| | | | | | |
| Equity Share Capital | 13.37 | 13.37 | 13.37 | 13.37 | 12.34 |
| Reserves And Surplus | 576.13 | 495.22 | 464.68 | 436.05 | 374.09 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 39.32 | 22.82 | 24.67 | 37.12 | 43.97 |
| Diluted EPS (Rs.) | 39.32 | 22.82 | 21.67 | 37.12 | 43.97 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 39.32 | 22.82 | 24.67 | 37.12 | 43.97 |
| Diluted EPS (Rs.) | 39.32 | 22.82 | 21.67 | 37.12 | 43.97 |
| | | | | | |
| PBITOE Margin (%) | 7.56 | 6.14 | 5.60 | 6.30 | 2.44 |
| PBTE Margin (%) | 10.81 | 8.11 | 7.50 | 7.76 | 3.42 |
| PBT Margin (%) | 12.36 | 8.11 | 7.50 | 7.76 | 7.97 |
| PAT Margin (%) | 8.21 | 5.30 | 5.38 | 8.51 | 10.54 |